Cerebral Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Cerebral Therapeutics?

Cerebral Therapeutics has 5 investors including Vivo Capital And RA Capital Management.

Q: How much funding has Cerebral Therapeutics raised to date?

Cerebral Therapeutics has raised obfuscated.

Overview

Cerebral Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Cerebral Therapeutics

CB Rank

35215

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

Founded

obfuscation

Private

Series C

Aurora, Colorado, United States

1-10

www.cerebraltherapeutics.com/

Biotechnology

Health Care

Neuroscience

Pharmaceutical

Therapeutics

Funding Rounds

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Daniel J. Abrams: Co-Founder & CEO
Past Role: Sierra Neuroscience Institute, Co-Founder & CEO
Guy Anthony: CFO
Past Role: Medicalis, CFO

Details

Legal Name

Cerebral Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Daniel J. Abrams

About the Company

Cerebral Therapeutics is a clinical-stage pharmaceutical company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy.

Phone Number

303 547 3448

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

CT-010

A proprietary formulation of the anti-epileptic drug valproic acid delivered directly into the brain via an implanted, refillable catheter and pump system for treating refractory epilepsy.

ICVRx™ Platform

A proprietary technology platform enabling direct-to-brain delivery of drugs, biologics, and oligonucleotide therapies, bypassing the blood-brain barrier for treating various neurological diseases.

Research & Development

Cerebral Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Cerebral Therapeutics	5	obfuscated obfuscation	Lynx1 Capital Management	Series C
obfuscated obfuscation	Series C - Cerebral Therapeutics	5	obfuscated obfuscation	Lynx1 Capital Management	Series C
obfuscated obfuscation	Series C - Cerebral Therapeutics	5	obfuscated obfuscation	Lynx1 Capital Management	Series C
obfuscated obfuscation	Series C - Cerebral Therapeutics	5	obfuscated obfuscation	Lynx1 Capital Management	Series C
obfuscated obfuscation	Series C - Cerebral Therapeutics	5	obfuscated obfuscation	Lynx1 Capital Management	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Cerebral Therapeutics	5	obfuscated obfuscation	Lynx1 Capital Management	Series C
obfuscated obfuscation	Series C - Cerebral Therapeutics	5	obfuscated obfuscation	Lynx1 Capital Management	Series C
obfuscated obfuscation	Series C - Cerebral Therapeutics	5	obfuscated obfuscation	Lynx1 Capital Management	Series C
obfuscated obfuscation	Series C - Cerebral Therapeutics	5	obfuscated obfuscation	Lynx1 Capital Management	Series C
obfuscated obfuscation	Series C - Cerebral Therapeutics	5	obfuscated obfuscation	Lynx1 Capital Management	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Vivo Capital	—	Series C - Cerebral Therapeutics	Mahendra Shah
Vivo Capital	—	Series C - Cerebral Therapeutics	Mahendra Shah
Vivo Capital	—	Series C - Cerebral Therapeutics	Mahendra Shah
Vivo Capital	—	Series C - Cerebral Therapeutics	Mahendra Shah
Vivo Capital	—	Series C - Cerebral Therapeutics	Mahendra Shah